D.Western Therapeutics Institute (6DW) Q2 2026 Earnings Report
DE:6DW Q2 2026 EPS Results
- Actual EPS
- -EUR 0.02
- Consensus EPS
- ―
- Beat/Miss
- ―
- One Year Ago EPS
- -EUR 0.02
DE:6DW Q2 2026 Revenue Results
- Actual Revenue
- EUR 101.82K
- Expected Revenue
- ―
- Beat/Miss
- ―
- YoY Revenue Growth
- -76.43%
Earnings Announcement Details
- Quarter
- Q2 2026
- Date
- 08/13/2026
- Time
- TBA
- Conference Call
- Thursday, August 13, 2026
DE:6DW Upcoming Earnings
D.Western Therapeutics Institute's next earnings date is estimated for November 12, 2026, based on past reporting schedules.
Q2 2026 Earnings Call Audio
No earnings call audio is available for this earnings event.
Q2 2026 Earnings Slide Deck
No slide deck is available for this earnings event.
Q2 2026 Earnings Call Summary
No earnings call summary is available for this earnings event.
DE:6DW Earnings History
| Report Date | Fiscal Quarter | Forecast / EPS | Last Year's EPS | EPS YoY Change | Press Release |
|---|---|---|---|---|---|
| Nov 12, 2026 | 2026 (Q3) | ―- | -0.02 | ― | ― |
| Aug 13, 2026 | 2026 (Q2) | ―-0.02 | -0.02 | 27.52% (+0.01) | |
| May 14, 2026 | 2026 (Q1) | ―-0.02 | -0.02 | 7.92% (+0.00) | |
| Feb 13, 2026 | 2025 (Q4) | ―-0.01 | -0.09 | 83.87% (+0.07) | |
| Nov 13, 2025 | 2025 (Q3) | ―-0.02 | -0.03 | 32.78% (+0.01) | |
| Aug 14, 2025 | 2025 (Q2) | ―-0.02 | -0.03 | 40.42% (+0.01) | |
| May 15, 2025 | 2025 (Q1) | ―-0.02 | -0.06 | 65.87% (+0.04) | |
| Feb 10, 2025 | 2024 (Q4) | ―-0.09 | -0.1 | 14.37% (+0.01) | |
| Nov 14, 2024 | 2024 (Q3) | ―-0.03 | -0.03 | 10.93% (+0.00) | |
| Aug 09, 2024 | 2024 (Q2) | ―-0.03 | -0.03 | -29.68% (-0.01) |
The table shows recent earnings report dates and whether the forecast was beat or missed. See the change in forecast and EPS from the previous year.
Beat Missed
